Rare diseases

Alnylam gives up on Onpattroā€™s US expansion after FDA rejects its rare heart disease indication

Alnylam gives up on Onpattroā€™s US expansion after FDA rejects its rare heart disease indication

Anika Sharma

Despite receiving an endorsement from an advisory committee, the FDA has reached a different conclusion regarding the benefit-risk profile of ...

Amgen Successfully Completes $27.8B Acquisition of Horizon After FTC Dispute Resolution

Amgen Successfully Completes $27.8B Acquisition of Horizon After FTC Dispute Resolution

Anika Sharma

Amgen has successfully concluded its monumental $27.8 billion acquisition of Horizon Therapeutics, triumphing over a legal challenge posed by the ...

Novartisā€™ iptacopan impresses in phase 3 trial for rare kidney disease

Novartisā€™ iptacopan impresses in phase 3 trial for rare kidney disease

Anika Sharma

Novartis is celebrating a significant achievement as its investigational oral factor B inhibitor reaches a crucial milestone in a phase ...

Ionisā€™ olezarsen slashes triglycerides and pancreatitis in rare disease patients

Ionisā€™ olezarsen slashes triglycerides and pancreatitis in rare disease patients

Anika Sharma

Ionis Pharmaceuticals has achieved a significant milestone in its phase 3 clinical trial for lipid-lowering therapy, bringing the company closer ...

filspari confirmatory trial results, travere filspari fda approval status, filspari igan drug, filspari kidney function endpoint, travere filspari phase 3 trial, filspari proteinuria reduction, filspari safety and efficacy igan

Filspari fails to confirm kidney benefit in IgAN, but Travere hopes to keep FDA approval

Anika Sharma

Half a year after securing accelerated approval for the treatment of a rare kidney ailment, Travere Therapeuticsā€™ groundbreaking drug, Filspari, ...

Clinigen, advocacy groups, rare diseases, NaviGATE program, Association of the British Pharmaceutical Industry

Clinigen launches initiative to bridge the gap between rare disease communities and pharma

Anika Sharma

Clinigen, a pharmaceutical services company based in the UK, is launching the NaviGATE initiative to empower patient advocacy groups within ...

AstraZeneca and Verge partner to discover AI-driven drugs for rare neurodegenerative diseases

AstraZeneca and Verge partner to discover AI-driven drugs for rare neurodegenerative diseases

Anika Sharma

Verge Genomics is expanding its roster of Big Pharma partnerships by teaming up with AstraZeneca in a substantial $42 million ...

Ipsen, Clementia, FDA, Roche, Pharma, rare diseases, FDA approval, Sohonos

FDA Grants Approval to Ipsen’s Sohonos Capsules, the First-Ever Treatment for Individuals with Fibrodysplasia Ossificans Progressiva

Anika Sharma

In 2019, Ipsen made a significant investment of $1 billion to acquire Clementia Pharmaceuticals and its rare disease drug, palovarotene. ...

Soft Tissue Sarcoma Symptoms, Types, Causes, Treatment and Future Directions

Soft Tissue Sarcoma: Symptoms, Types, Causes, Treatment and Future Directions

SG Tylor

What is Soft Tissue Sarcoma? Vascular tumors are a type of soft tissue sarcoma that can affect the blood vessels ...

Vaginal Cancer: A Comprehensive Guide to Symptoms, Types, Causes, Treatment and More

Vaginal Cancer: A Comprehensive Guide to Symptoms, Types, Causes, Treatment and More

SG Tylor

Vaginal cancer is a rare but serious condition that affects the muscular tube that connects your uterus with your outer ...